Abstract
Advances in the past several years have revolutionaized the treatment of CML. The basic biology of CML, the emerging long-term data regarding imatinib therapy, and emerging treatment are discussed in this article.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S-41-S-45 |
| Journal | JNCCN Journal of the National Comprehensive Cancer Network |
| Volume | 3 |
| Issue number | SUPPL. 1 |
| State | Published - Nov 2005 |
Keywords
- Allogenic stem cell transplantation
- Chronic myelogenous leukemia
- Cytogenic monitoring
- Imatinib
- Tyrosine inhibitors
ASJC Scopus subject areas
- Oncology
Fingerprint
Dive into the research topics of 'Trends in the management of chronic myelogenous leukemia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS